HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antineoplastic efficacy of melphalan and N-(2-chloroethyl)-N-nitrosocarbamoyl-omega-lysine, in combination with diazoxide or insulin in autochthonous mammary carcinoma of the Sprague-Dawley rat.

Abstract
The anticancer activity of melphalan and N-(2-chloroethyl)-N-nitrosocarbamoyl-omega-lysine (CNC-omega-Lys), was compared in the autochthonous, methylnitrosourea-induced mammary carcinoma of the Sprague-Dawley rat. In addition, the influence on the therapeutic efficacy of the combination with diazoxide, causing a mild, reversible diabetes, and with insulin was investigated. The comparison of melphalan and CNC-omega-Lys clearly showed the superiority of melphalan. Both compounds displayed a significant tumour inhibition in their medium and the highest dosages in comparison to the untreated control. The combination with diazoxide resulted for almost all groups in an increased tumour inhibition. Only the lowest dose of CNC-omega-Lys + diazoxide did not reduce the tumour volume significantly versus the control group. The combination with insulin, however, resulted in a loss of tumour inhibition compared to the effect of the cytotoxic drug alone, although in these groups, too, a significant decrease of tumour volumes versus controls could be observed. Mortality was within tolerable limits (less than 20%) through the treatment period for all experimental groups. Median lifespans were increased in all therapy groups, but no additional benefit could be observed in the combination treatment groups.
AuthorsT Klenner, M R Berger, O Zelezny, M Fink, D Schmähl
JournalJournal of cancer research and clinical oncology (J Cancer Res Clin Oncol) Vol. 116 Issue 1 Pg. 45-50 ( 1990) ISSN: 0171-5216 [Print] Germany
PMID2107182 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Insulin
  • Nitrosourea Compounds
  • N-(2-chloroethyl)-N-nitrosocarbamoyl-omega-lysine
  • Lysine
  • Diazoxide
  • Melphalan
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Diazoxide (administration & dosage)
  • Female
  • Insulin (administration & dosage)
  • Lysine (administration & dosage, analogs & derivatives)
  • Mammary Neoplasms, Experimental (drug therapy)
  • Melphalan (administration & dosage)
  • Nitrosourea Compounds (administration & dosage)
  • Rats
  • Rats, Inbred Strains

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: